RIG‐I‐mediated innate immune signaling in tumors reduces the therapeutic effect of oncolytic vesicular stomatitis virus
Abstract Background Oncolytic viral therapy is a promising method for tumor treatment. Currently, several oncolytic viruses (OVs) have been used as tumor therapy at different phases of research and clinical trials. OVs not only directly lyse tumor cells due to viral replication but also initiate hos...
Main Authors: | Pengfei Zhang, Xinyu Han, Weiqi Tan, Dahua Chen, Qinmiao Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14740 |
Similar Items
-
Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants
by: Lisa Pipperger, et al.
Published: (2021-01-01) -
Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions
by: Molly C. Holbrook, et al.
Published: (2021-03-01) -
Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus
by: Dakota W. Goad, et al.
Published: (2022-03-01) -
Characterization of the Impact of Oncolytic Vesicular Stomatitis Virus on the Trafficking, Phenotype, and Antigen Presentation Potential of Neutrophils and Their Ability to Acquire a Non-Structural Viral Protein
by: Ashley A. Stegelmeier, et al.
Published: (2020-09-01) -
Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a “Hammer” and “Anvil”
by: Michael Karl Melzer, et al.
Published: (2017-02-01)